aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.250
+0.010 (0.31%)
At close: Oct 25, 2024, 4:00 PM
3.251
+0.001 (0.02%)
After-hours: Oct 25, 2024, 7:50 PM EDT
aTyr Pharma Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for aTyr Pharma stock have an average target of 19.25, with a low estimate of 9.00 and a high estimate of 35. The average target predicts an increase of 492.31% from the current stock price of 3.25.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for aTyr Pharma stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|
| Strong Buy | 1 | 2 | 2 |
| Buy | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 2 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $17 | Buy | Initiates | $17 | +423.08% | Oct 4, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +176.92% | Sep 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +976.92% | Aug 15, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $16 | Buy | Reiterates | $16 | +392.31% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +976.92% | Aug 1, 2024 |
Financial Forecast
Revenue This Year
293.76K
from 353.00K
Decreased by -16.78%
Revenue Next Year
6.34M
from 293.76K
Increased by 2,057.88%
EPS This Year
-0.94
from -0.94
EPS Next Year
-0.83
from -0.94
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 525,000 | 25.6M | 171.9M | ||
| Avg | 293,760 | 6.3M | 69.5M | ||
| Low | 196,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 48.7% | 8,630.9% | 2,611.6% | ||
| Avg | -16.8% | 2,057.9% | 996.0% | ||
| Low | -44.5% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.92 | -0.67 | 0.69 | ||
| Avg | -0.94 | -0.83 | -0.10 | ||
| Low | -0.94 | -0.95 | -0.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.